Vascular endothelial growth factor gene polymorphisms and endometriosis risk: A meta-analysis

Archives of Gynecology and Obstetrics

Volumn 286, Issue 1, 2012, Pages 139-146

  Liang, Shoujun ^a,b   Huang, Yin ^b   Fan, Yujuan ^a,b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Endometriosis; Gene polymorphisms; Meta analysis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ARTICLE; ENDOMETRIOSIS; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HETEROZYGOTE; HUMAN; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VASCULOTROPIN GENE;

ENDOMETRIOSIS; FEMALE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864440004     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2270-1     Document Type: Article

References (38)

1. Giudice LC, Kao LC (2004) Endometriosis. Lancet 364(9447): 1789-1799. doi:10.1016/S0140-6736(04)17403-5
2. Simpson ER (2000) Role of aromatase in sex steroid action. J Mol Endocrinol 25(2):149-156 pii:JME00938
3. Taylor RN, Lebovic DI, Mueller MD (2002) Angiogenic factors in endometriosis. Ann N Y Acad Sci 955:89-100 discussion 118, 396-406
4. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, Smith SK (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endome-triosis and is regulated by ovarian steroids. J Clin Invest 98(2): 482-489. doi:10.1172/JCI118815
5. Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL, Tseng JF (1997) Angiogenesis and macrophage activation in endometri-osis. Ann N Y Acad Sci 828:194-207
6. Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vas-siliadis S (2003) Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 3(1):81-89 pii:S1567-5769(02)00216-3
7. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M (1998) Vascular endothelial growth factor (VEGF) in endome-triosis. Hum Reprod 13(6):1686-1690
8. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L (2002) Expression of vascular endothelial growth factor and thrombo-spondin-1 mRNA in patients with endometriosis. Fertil Steril 78(1):148-153 pii:S0015028202031874
9. Vincenti V, Cassano C, Rocchi M, Persico G (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93(8):1493-1495
10. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12(8):1232-1235. doi:10.1006/cyto. 2000.0692
11. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC (2003) Vascular endothelial growth factor gene -460 C/T polymorphism is a biomarker for prostate cancer. Urology 62(2):374-377 pii:S0090 429503002681
12. Han Y, Zhou Y, Zheng S (2002) Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus. Zhonghua Fu Chan Ke Za Zhi 37(9):539-541
13. Ku KT, Wan L, Peng HC, Tsai MH, Tsai CH, Tsai FJ (2005) Vascular endothelial growth factor gene -460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 41(5):497-502. doi:10.1016/j.oraloncology.2004.12.009
14. Zhao ZZ, Nyholt DR, Thomas S, Treloar SA, Montgomery GW (2008) Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Mol Hum Reprod 14(9):531-538. doi:10.1093/molehr/gan043
15. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
16. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 pii:0197-2456(86)90046-2
17. Liu Q, Li Y, Zhao J, Zhou RM, Wang N, Sun DI, Duan YN, Kang S (2009) Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis. Chin J Med Genet 26(2):165-169
18. Zhao J, Li Y, Liu Q (2009) Study on the association of SNPs of VEGF gene with risk of endometriosis and adenomyosis. Zhonghua Liu Xing Bing Xue Za Zhi 30(7):751-752
19. Kim JG, Kim JY, Jee BC, Suh CS, Kim SH, Choi YM (2008) Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women. Fertil Steril 89(1):243-245. doi: 10.1016/j.fertnstert.2007.02.023
20. 0-untrans-lated region: association with a higher susceptibility to endome-triosis. J Reprod Med 49(6):468-472
21. 0-untrans-lated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 20(7):1844-1849. doi:10.1093/humrep/deh852
22. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY (2005) Vascular endothelial growth factor gene ?405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 20(10):2904-2908. doi:10.1093/humrep/dei146
23. Ikuhashi Y, Yoshida S, Kennedy S, Zondervan K, Takemura N, Deguchi M, Ohara N, Maruo T (2007) Vascular endothelial growth factor ?936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population. Acta Obstet Gynecol Scand 86(11):1352-1358. doi:10.1080/0001634 0701644991
24. Gentilini D, Somigliana E, Vigano P, Vignali M, Busacca M, Di Blasio AM (2008) The vascular endothelial growth factor ?405GC polymorphism in endometriosis. Hum Reprod 23(1):211-215. doi:10.1093/humrep/dem341
25. Cosin R, Gilabert-Estelles J, Ramon LA, Espana F, Gilabert J, Romeu A, Estelles A (2009) Vascular endothelial growth factor polymorphisms (-460C/T, ?405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertil Steril 92(4):1214-1220. doi:10.1016/j. fertnstert.2008.08.079
26. Liu Q, Li Y, Zhao J, Sun DL, Duan YN, Wang N, Zhou RM, Kang S (2009) Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum Reprod 24(10):2660-2666. doi:10.1093/humrep/dep208
27. Attar R, Agachan B, Kuran SB, Toptas B, Eraltan IY, Attar E, Isbir T (2010) Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis. In Vivo 24(3):297-301
28. Lamp M, Saare M, Laisk T, Karro H, Kadastik U, Metspalu A, Peters M, Salumets A (2010) Genetic variations in vascular endothelial growth factor but not in angiotensin I-converting enzyme genes are associated with endometriosis in Estonian women. Eur J Obstet Gynecol Reprod Biol 153(1):85-89. doi: 10.1016/j.ejogrb.2010.07.021
29. Altinkaya SO, Ugur M, Ceylaner G, Ozat M, Gungor T, Ceylaner S (2011) Vascular endothelial growth factor ?405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women. Arch Gynecol Obstet 283(2): 267-272. doi:10.1007/s00404-009-1344-1
30. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Forsti A (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11(10):3647-3653. doi:10.1158/1078-0432.CCR-04-1803
31. Vigano P (2003) Perspectives on endometriosis: new physio-pathologic approaches and treatments. J Gynecol Obstet Biol Reprod (Paris) 32(8 Pt 2):S28-S31 pii:MDOI-JGYN-12-2003-32-8-C2-0368-2315-101019-ART7
32. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37(6):443-448
33. Eroglu A, Gulec S, Kurtman C, Cam R, Akar N (2006) Vascular endothelial growth factor 936 C/T polymorphism in cancer patients. Ann Oncol 17(9):1467-1468. doi:10.1093/annonc/mdl075
34. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK (2008) Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 CT) gene and colon cancer in Korea. Anticancer Res 28(2B):1271-1276
35. Eroglu A, Ozturk A, Cam R, Akar N (2008) Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol 25(1):54-55. doi:10.1007/s12032-007-0046-4
36. Bao G, Wang M, Guo S, Han Y, Xu G (2011) Vascular endo-thelial growth factor ?936 C/T gene polymorphism and glioma risk in a Chinese Han population. Genet Test Mol Biomarkers 15(1-2):103-106. doi:10.1089/gtmb.2010.0141
37. Wu X, Li D, Liu Z, Wan X, Wu Y, Jiang C, Qian Q (2011) Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study. Mol Biol Rep 38(3):1949-1955. doi: 10.1007/s11033-010-0316-7
38. Zondervan KT, Cardon LR, Kennedy SH (2002) What makes a good case-control study? design issues for complex traits such as endometriosis. Hum Reprod 17(6):1415-1423